In vivo gene delivery to tumor cells by transferrin-streptavidin-DNA conjugate

FASEB Journal

Volumn 14, Issue 13, 2000, Pages 2108-2118

  Sato, Yasushi ^a   Yamauchi, Naofumi ^a   Takahashi, Minoru ^a   Sasaki, Katsunori ^a   Fukaura, Junki ^a   Neda, Hiroshi ^a   Fujii, Shigeyuki ^a   Hirayama, Michiaki ^a   Itoh, Yoshinori ^a   Koshita, Yoshikazu ^a   Kogawa, Katsuhisa ^a   Kato, Junji ^a   Sakamaki, Sumio ^a   Niitsu, Yoshiro ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Gene therapy; Metastasis; Plasmid DNA; Transferrin receptor; Tumor targeting

Indexed keywords

BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; MESSENGER RNA; PLASMID DNA; STREPTAVIDIN; THYMIDINE KINASE; TRANSFERRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTINYLATION; CANCER THERAPY; CELL KINETICS; CONTROLLED STUDY; DRUG CONJUGATION; FEMALE; GENE CONSTRUCT; GENE EXPRESSION; GENE TARGETING; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; STOICHIOMETRY; SUICIDE GENE; TRANSGENE; TUMOR CELL;

ADENOVIRIDAE; ANIMALIA; HERPES; MUS MUSCULUS; SIMPLEXVIRUS;

EID: 0033820595     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.99-1052com     Document Type: Article

References (55)

1. Receptor mediated endocytosis of transferrin in K562 cell
2. Receptor-mediated endocytosis of transferrin and the uptake of Fe in K562 cells: Identification of a nonlysosomal acidic compartment
3. Modulation of cell surface iron transferrin receptors by cellular density and state of activation
4. Transferrin and transferrin receptors in carcinoma of the breast
5. Transferrin receptors in human tissues: Their distribution and possible clinical relevance
6. Characterization of a transferrin-diphtherotoxin conjugate
7. Tumor regression with regional distribution of the targeted toxin TF-CRM107 in patients with malignant brain tumors
8. A highly cytotoxic human transferrin-ricin A chain conjugate used to select receptor-modified cells
9. Killing of K562 cells with conjugates between human transferrin and a ribosome-inactivating protein (SO-6)
10. Engineering receptor-mediated cytotoxicity into human ribonucleases by steric blockade of inhibitor interaction
11. Intracellular metabolism and cytotoxicity of transferrin-neocarzinostatin conjugate of differing molar ratios
12. Kinetics of internalization and cytotoxicity of transferrin-neocarzinostatin conjugate on human leukemia cell line, K562
13. Transferrin conjugates of adriamycin are cytotoxic without intercalating nuclear DNA
14. Transferrin-polycation conjugates as carriers for DNA uptake into cells
15. Transferrin-polycation-DNA complexes: The effect of polycations on the structure of the complex and DNA delivery to cells
16. Receptor-mediated endocytosis of transferrin-polycation conjugates: An efficient way to introduce DNA into hematopoietic cells
17. Receptor-mediated transport of DNA into eukaryotic cells
18. Strategies to accomplish gene delivery via the receptor-mediated endocytosis pathway
19. Glycerol enhancement of ligand-polylysine/DNA transfection
20. Glycerol and polylysine synergize in their ability to rupture vesicular membranes: A mechanism for increased transferrin-polylysine-mediated gene transfer
21. Adenovirus enhancement of transferrin-polylysine-mediated gene delivery
22. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes
23. High-efficiency receptor-mediated delivery of small and large (48 kilobase gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles
24. Generation of effective cancer vaccines genetically engineered to secrete cytokines using adenovirus-enhanced transferrinfection (AVET)
25. Receptor ligand-facilitated gene transfer: Enhancement of liposome-mediated gene transfer and expression by transferrin
26. Transferrinliposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro
27. Redesigning nature's poisons to create anti-tumor reagents
28. Reconbinant immunotoxin containing a disulfide-stabilized Fv directed at erbB2 that does not require proteolytic activation
29. Immunotoxin made with a recombinant form of pseudomonas exotoxin A that do not require proteolysis for activity
30. A high yield purification of the human transferrin receptor and properties of its major extracellular fragment
31. A spectrophotometric assay for avidin and biotin based on binding of dyes by avidin
32. Efficient selection for high-expression transfectants with a novel eukaryotic vector
33. Transfection of glutathione S-transferase (GST-π) antisense complementary DNA increase the sensitivity of a colon cancer cell line to adriamysine, cisplatin, melphalan, and etoposide
34. Long term correction of bilirubin-UDP-glucuronosyltransferase deficiency in gunn rats by administration of a recombinant adenovirus during the neonatal period
35. Augmented antitumor effects of killer cells induced by tumor necrosis factor gene-transduced autologous tumor cells from gastrointestinal cancer patients
36. Production of high-titer helper free retroviruses by transient transfection
37. Use of a recombinant retrovirus to study post-implantation cell lineage in mouse embryos
38. Bystander effect caused by suicide gene expression indicates the feasibility of gene therapy for hepatocellular carcinoma
39. Improved engraftment of human tumours in SCID mice pretreated with radiation and anti-asialo GM1
40. Concentrations of thrombopoietin in bone marrow in normal subjects and in patients with idiopathic thrombocytopenic purpura aplastic anemia, and essential thrombocythemia correlate with its mRNA expression of bone marrow stromal cells
41. Transforming growth factor β1 (TGF-β1) induces thrombopoietin from bone marrow stromal cells, which stimulates the expression of TGF-β receptor on megakaryocytes and, in turn, renders them susceptible to suppression by TGF-β itself with high specificity
42. The receptor for transferrin on murine myoma cells: One-step purification based on its physiology, and partial amino acid sequence
43. Analysis and isolation of human transferrin receptor using the OKT-9 monoclonal antibody covalently crosslinked to magnetic beads
44. Further studies on targeted DNA transfer to cells using a highly efficient delivery system of biotinylated transferrin and biotinylated polylysine complexed to streptavidin
45. Non-radioactive hybridization probes prepared by the chemical labeling of DNA and RNA with a novel reagent, photobiotin
46. 'Green mice' as a source of ubiquitous green cells
47. Endocytosis of the transferrin receptor is altered during differentiation of murine erythroleukemia cells
48. Structural characteristics of the mouse transferrin receptor
49. Heterogeneity of the human transferrin receptor and use of anti-transferrin receptor antibodies to detect tumors in vivo
50. Transferrin receptor on endothelium of brain capillaries
51. Expression and extracellular release of transferrin receptors during peripheral erythroid progenitor cell differentiation in liquid culture
52. Serum transferrin receptor as a new index of erythropoiesis
53. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle
54. High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA
55. Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA